Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$63.15 - $72.88 $94,409 - $108,955
-1,495 Reduced 28.44%
3,762 $258,000
Q1 2024

May 14, 2024

BUY
$71.58 - $87.29 $376,296 - $458,883
5,257 New
5,257 $385,000
Q3 2023

Nov 14, 2023

BUY
$73.94 - $80.67 $804,541 - $877,770
10,881 Added 202.1%
16,265 $1.22 Million
Q2 2023

Aug 14, 2023

BUY
$76.01 - $86.7 $409,237 - $466,792
5,384 New
5,384 $415,000
Q3 2022

Nov 14, 2022

BUY
$59.54 - $68.01 $1.08 Million - $1.24 Million
18,203 New
18,203 $1.12 Million
Q2 2022

Aug 12, 2022

SELL
$57.72 - $65.01 $406,983 - $458,385
-7,051 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$57.92 - $72.58 $183,432 - $229,860
3,167 Added 81.54%
7,051 $419,000
Q4 2021

Feb 14, 2022

BUY
$64.88 - $73.64 $251,993 - $286,017
3,884 New
3,884 $282,000
Q2 2021

Aug 13, 2021

SELL
$63.47 - $69.35 $429,691 - $469,499
-6,770 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$60.0 - $68.46 $2,760 - $3,149
-46 Reduced 0.67%
6,770 $438,000
Q4 2020

Feb 11, 2021

BUY
$56.65 - $64.55 $125,593 - $143,107
2,217 Added 48.21%
6,816 $397,000
Q3 2020

Nov 13, 2020

BUY
$62.1 - $78.08 $285,597 - $359,089
4,599 New
4,599 $291,000
Q1 2020

May 13, 2020

SELL
$62.63 - $80.22 $895,671 - $1.15 Million
-14,301 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$61.62 - $67.78 $881,227 - $969,321
14,301 New
14,301 $929,000
Q2 2019

Aug 14, 2019

SELL
$61.87 - $69.38 $386,254 - $433,139
-6,243 Closed
0 $0
Q1 2019

May 13, 2019

SELL
$62.53 - $70.05 $106,738 - $119,575
-1,707 Reduced 21.47%
6,243 $406,000
Q4 2018

Feb 13, 2019

BUY
$60.54 - $79.0 $481,293 - $628,050
7,950 New
7,950 $498,000
Q1 2018

May 14, 2018

SELL
$72.84 - $88.8 $721,116 - $879,120
-9,900 Closed
0 $0
Q4 2017

Feb 09, 2018

BUY
$71.15 - $83.52 $704,385 - $826,848
9,900
9,900 $709,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Dynamic Technology Lab Private LTD Portfolio

Follow Dynamic Technology Lab Private LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.